Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Maria Croce

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 9, 2012
Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1Daniela D'Angelo, Dario Palmieri, Paula Mussnich, et al.
Cancer Research|April 15, 2010
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PEDMariarosaria Incoronato, Michela Garofalo, Loredana Urso, et al.
The Biochemical Journal|February 17, 2005
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2)Sabrina Battista, Monica Fedele, Josefina Martinez Hoyos, et al.
The Journal of Clinical Endocrinology and Metabolism|September 12, 2012
Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) geneMarianna Colamaio, Gaetano Calì, Daniela Sarnataro, et al.
Oncotarget|March 19, 2016
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumorsMatteo Rossi, David Colecchia, Gennaro Ilardi, et al.
Cancer Research|May 27, 2010
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cellsFrancesca Fornari, Maddalena Milazzo, Pasquale Chieco, et al.
Nucleic Acids Research|March 15, 2014
miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAsAlessandro Laganà, Mario Acunzo, Giulia Romano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocalityLaura Gramantieri, Francesca Fornari, Manuela Ferracin, et al.
Plos One|March 26, 2013
cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomasValentina Manfè, Edyta Biskup, Ayalah Willumsgaard, et al.
Endocrine-Related Cancer|October 5, 2007
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycleRosa Visone, Lucia Russo, Pierlorenzo Pallante, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|May 9, 2012
Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1Daniela D'Angelo, Dario Palmieri, Paula Mussnich, et al.
Cancer Research|April 15, 2010
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PEDMariarosaria Incoronato, Michela Garofalo, Loredana Urso, et al.
The Biochemical Journal|February 17, 2005
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2)Sabrina Battista, Monica Fedele, Josefina Martinez Hoyos, et al.
The Journal of Clinical Endocrinology and Metabolism|September 12, 2012
Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) geneMarianna Colamaio, Gaetano Calì, Daniela Sarnataro, et al.
Oncotarget|March 19, 2016
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumorsMatteo Rossi, David Colecchia, Gennaro Ilardi, et al.
Cancer Research|May 27, 2010
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cellsFrancesca Fornari, Maddalena Milazzo, Pasquale Chieco, et al.
Nucleic Acids Research|March 15, 2014
miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAsAlessandro Laganà, Mario Acunzo, Giulia Romano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocalityLaura Gramantieri, Francesca Fornari, Manuela Ferracin, et al.
Plos One|March 26, 2013
cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomasValentina Manfè, Edyta Biskup, Ayalah Willumsgaard, et al.
Endocrine-Related Cancer|October 5, 2007
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycleRosa Visone, Lucia Russo, Pierlorenzo Pallante, et al.
Pageof 6